Divalproex Sodium
Product Images NDC 50090-4187

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 50090-4187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph comparing the percentage reduction in CPS rate between Divalproex Sodium Delayed-Release Tablets and placebo. The x-axis shows the percentage of patients, and the y-axis displays the percentage reduction in CPS rate, with improvement indicated upwards and worsening downwards. Two curves represent the outcomes for the medication and placebo groups respectively.*

FDA Label Image

Figure2 (Figure2)

A cumulative distribution plot showing the percentage reduction in CPS rate versus the percentage of patients for high dose and low dose Divalproex Sodium delayed-release tablets. The vertical axis ranges from -100% to 100% reduction, indicating worsening to improvement, while the horizontal axis ranges from 0% to 100% patients.*

FDA Label Image

Figure3 (Figure3)

A bar graph comparing results between placebo and Divalproex Sodium extended-release tablets. The vertical axis shows values from 0.0 to 1.2. The placebo bar reaches 0.6, while the Divalproex Sodium extended-release tablets bar reaches 1.2, marked with an asterisk. The graph visually contrasts the two treatments' measured effects.*

FDA Label Image

Label Image (Lbl500904187)

Divalproex Sodium 500 mg extended-release unit dose tablets by A-S Medication Solutions. The label includes dosage instructions for once-daily dosing, storage conditions between 20 to 25 degrees Celsius, and packaging information. It features the product NDC 50090-4187-0 and states that each tablet contains divalproex sodium equivalent to 500 mg of valproic acid activity.*

FDA Label Image

Structure (Structure)

Chemical structure of Divalproex Sodium, showing the molecular arrangement including sodium ion and valproate components represented with hydrocarbon chains, carboxyl groups, and associated chemical bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.